Dichloromethane → (2R,3R,4S,5R,6E)-7-(2-bromophenyl)-3,4,5-trihydroxy-2-methoxy-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]hept-6-enamide
反応式
[Br:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1/[CH:8]=[CH:9]/[C@H:10]([C@@H:12]1[O:16][C:15](=[O:17])[C@H:14]([O:18][CH3:19])[C@@H:13]1[OH:20])[OH:11].Cl.[NH2:22][C@@H:23]1[C:29](=[O:30])[N:28]([CH3:31])[C:27]2[CH:32]=[CH:33][CH:34]=[CH:35][C:26]=2[O:25][CH2:24]1.C(C(CCCC)C([O-])=O)C.[Na+].C(Cl)Cl>C1COCC1>[Br:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1/[CH:8]=[CH:9]/[C@@H:10]([OH:11])[C@H:12]([OH:16])[C@@H:13]([OH:20])[C@@H:14]([O:18][CH3:19])[C:15]([NH:22][C@@H:23]1[C:29](=[O:30])[N:28]([CH3:31])[C:27]2[CH:32]=[CH:33][CH:34]=[CH:35][C:26]=2[O:25][CH2:24]1)=[O:17]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
90 mg of 45 (0.22 mmol), 51 mg of 6 (0.22 mmol) and 93 mg of sodium 2-ethylhexanoate (0.56 mmol) in 2.0 mL of THF are successively introduced into a 10 mL round-bottomed flask, with stirring and under an argon atmosphere. The stirring is maintained at RT for 24 h. 20 mL of CH2Cl2 are added to the reaction medium. The mixture is successively washed with 10 mL of an HCl solution (1N), 10 mL of water saturated with NaCl. The organic phase is dried over anhydrous magnesium sulphate, filtered and then evaporated to dryness. The crude product is chromatographed on a silica cartridge (9 g, eluent, AcOEt/heptane:85/15). 49 mg of expected product Ex18 (white solid) are recovered.
後処理
- washThe mixture is successively washed with 10 mL of an HCl solution (1N), 10 mL of water saturated with NaCl
- dry with materialThe organic phase is dried over anhydrous magnesium sulphate
- filtrationfiltered
- customevaporated to dryness
- customThe crude product is chromatographed on a silica cartridge (9 g, eluent, AcOEt/heptane:85/15)
- custom49 mg of expected product Ex18 (white solid) are recovered
出典と根拠
- ORDレコード
- ord-9db73c273f97403289f9e1923cc9d727
- 出典データセット
- uspto-grants-2011_08
- 特許番号
- US07994161B2
反応ノート
読み込み中…